Stocktoria

Advanced Biomed Inc. ADVB

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2025-03-06

Advanced Biomed Inc. statistics & valuation

Market cap$7.4M
P / E1.1×
P / S58.1×
P / B0.6×
Net margin5231.3%
Return on equity54.4%
Return on capital-50.8%
Graham number +1079.9%$29.85

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($29.85); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
5231.30% 202420252026
Gross margin (%)
202420252026
Operating margin (%)
-4883.80% 202420252026
Return on equity (%)
-167.30% -93.70% 54.40% 202420252026
Shares outstanding
20.0M 1.1M 1.7M 202420252026
Net debt ($)
202420252026
Share buybacks ($)
202420252026
Return on assets (%)
-62.40% -14.30% 48.60% 202420252026
Free cash flow margin (%)
202420252026
Debt / equity (×)
202420252026
EPS ($)
-$0.14 -$3.18 $5.33 202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024
Operating margin-4883.8%——
Net margin5231.3%——
Return on assets48.6%-14.3%-62.4%
Return on equity54.4%-93.7%-167.3%
Current ratio9.331.161.12

Computed from company filings · US · as of 2026-06-30. Facts plus Stocktoria's own computed scores — not investment advice.